Xencor Common Stock share price logo

Xencor Common Stock

NASDAQ: XNCR

Small Cap

$14.08

+0.07

(+0.50%)

as on

Xencor Common Stock Stock Performance

as on June 24, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $13.90
    $14.49
    downward going graph

    1.28%

    Downside

    2.91%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $6.92
    $18.69
    downward going graph

    50.85%

    Downside

    32.74%

    Upside

    downward going graph

Xencor Common Stock share price movements today

Previous Close
$14.01
Open
$13.90
Volume
889.5K
Day's Low - High
$13.90 - $14.49
52 Week Low - High
$6.92 - $18.69

Xencor Common Stock Historical Returns

1 Month Return
+ 24.49 %
3 Month Return
+ 18.42 %
1 Year Return
+ 70.25 %
3 Year Return
-44.89 %
5 Year Return
-60.9 %

Xencor Common Stock Stock Fundamentals & Key Indicators

Check Xencor Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.0B

EPS (TTM)

-3.9944

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-201.8M

Revenue (TTM)

97.4M

Profit Margin

-177.10%

Return On Equity TTM

-29.84%

Xencor Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Xencor Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$1.0B-60.9%NA-177.10%NA
BUY$38.2B65.93%71.9612.55%NA
BUY$118.5B144.05%27.735.51%NA
BUY$64.2B13.51%14.9529.65%0.59%

Stock Returns calculator for Xencor Common Stock Stock including INR - Dollar returns

The Xencor Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Xencor Common Stock investment value today

Current value as on today

₹1,86,290

Returns

₹86,290

(+86.29%)

Returns from Xencor Common Stock Stock

₹70,254 (+70.25%)

Dollar Impact

₹16,036 (+16.04%)

Analyst Recommendation on Xencor Common Stock Stock

Based on 19 analysts

BUY

84.21%

Buy

10.53%

Hold

5.26%

Sell

Based on 19 analysts, 84.21% of analysts recommend a 'BUY' rating for Xencor Common Stock. Average target price of $28.5

Xencor Common Stock Share Price Target

Get share price movements and forecasts by analysts on Xencor Common Stock.

What analysts predicted

50.6%UPSIDE

Target Price

$28.5

Current Price

$14.08

Analyzed by

19 Analysts

Target

$28.50

Xencor Common Stock target price $28.5, a slight upside of 50.6% compared to current price of $14.08. According to 19 analysts rating.

Indian Investors' Interest in Xencor Common Stock Stock

Search interest for Xencor Common Stock Stock has increased by 5% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:5% versus previous 30 day period

Xencor Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
50
15
16
17
70
32
43
20
28
4
Gross Profit
47
-40
13
-40
70
30
40
-33
25
1
Operating Income
-28
-54
-62
-55
4
-43
-33
-47
-53
-77
EBITDA
-3
-61
-63
-35
-15
-36
-20
4
5
-121
Interest Expense
6
9
0
0
33
8
8
7
7
4
Depreciation
3
3
3
3
2
2
2
2
2
2
Income Before Tax
-12
-74
-67
-47
-52
-48
-31
-6
-4
-128
Income Tax Expense
13
0
0
-1
1
0
0
-
2
0
Net Income
-26
-73
-65
-46
-53
-48
-30
-6
-6
-128
Net Profit Margin
-51.30%
-459.09%
-388.93%
-260.10%
-76.38%
-147.92%
-70.69%
-28.70%
-23.56%
-2854.65%

Xencor Common Stock Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
87
35
40
156
122
275
164
168
110
125
Gross Profit
87
35
40
38
122
275
164
-85
-117
115
Operating Income
22
-53
-79
13
-76
43
-82
-138
-178
-177
EBITDA
24
-51
-76
18
-71
51
-73
-125
-186
-46
Interest Expense
0
0
0
17
-
7
36
6
36
31
Depreciation
-
2
3
4
5
7
8
10
12
10
Income Before Tax
24
-49
-70
27
-69
82
-54
-120
-234
-89
Income Tax Expense
0
0
8
0
-5
-7
0
5
1
2
Net Income
23
-48
-70
26
-63
82
-55
-126
-232
-91
Net Profit Margin
26.99%
-137.00%
-173.41%
17.15%
-51.79%
30.04%
-33.53%
-74.90%
-210.53%
-73.20%

Xencor Common Stock Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-68
-68
-48
-54
-48
-30
-6
85
-128
Operating Cash Flow
-55
-67
-26
-55
-16
-36
-30
-51
-67
Investing Cash Flow
32
66
-163
57
11
40
14
71
26
Financing Cash Flow
0
1
187
10
2
0
-
6
0
Change in Cash
-22
0
-1
11
-1
4
-16
25
-39

Xencor Common Stock Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-48
-70
26
-69
82
-55
-126
-236
-91
Operating Cash Flow
-33
-79
64
-5
-16
24
85
-202
-135
Investing Cash Flow
31
-164
-50
100
-46
-119
-
-7
139
Financing Cash Flow
3
254
10
18
43
5
26
197
8
Change in Cash
2
9
24
113
-20
-89
0
-12
13

Global Institutional Holdings in Xencor Common Stock

Funds
Holdings
T. Rowe Price Associates, Inc.
2.1%
Morgan Stanley - Brokerage Accounts
2.1%
Bank of America Corp
1.03%
Royal Bank of Canada
1.85%
Baker Bros Advisors LP
1.49%

Insights on Xencor Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, XNCR stock has moved up by 10.2%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, XNCR has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Xencor, Inc. Common Stock has experienced a drawdown of -44.9%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 24.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -6.02M → -128.91M (in $), with an average decrease of 924.1% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 28.23M → 4.51M (in $), with an average decrease of 84.0% per quarter

About Xencor Common Stock

Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases. The company provides Ultomiris to treat patients with atypical hemolytic uremic syndrome, generalized myasthenia gravis, and neuromyelitis optica spectrum disororder; and Monjuvi for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma. It also develops XmAb819, a bispecific antibody to treat renal cell carcinoma; XmAb541, which is in Phase I for the treatment of ovarian cancer; XmAb808, a bispecific antibody that binds to the broadly expressed tumor antigen; XmAb942, which is in clinical development for patients with Crohn's disease and ulcerative colitis; Plamotamab, a bispecific T-cell, which is in Phase Ib study to treat rheumatoid arthritis; and XmAb657 for patients with idiopathic inflammatory myopathies. Further, the company develops Xaluritamig, a bispecific T-cell engager that treats prostate cancer; ASP2138 to treat gastric, gastroesophageal junction, and pancreatic cancers; JNJ-9401 to treat metastatic castration-resistant prostate cancer; Obexelimab, an antibody to treat patients with autoimmune diseases; Tobevibart, a treatment for chronic hepatitis Delta; Zaltenibart to treat paroxysmal nocturnal hemoglobinuria and other alternative pathway disorders; Teropavimab and zinlirvimab to treat human immunodeficiency virus; Novartis, an antibody drug candidate that uses XmAb Fc technologies; and JNJ-1493 to treat B-cell malignancies. The company was incorporated in 1997 and is headquartered in Pasadena, California.
OrganisationXencor Common Stock
Headquarters465 North Halstead Street, Pasadena, CA, United States, 91107
IndustryBiotechnology
CEODr. Bassil I. Dahiyat Ph.D.
E-voting on sharesClick here to vote

Key Management of Xencor Common Stock

Name

Title

Mr. Charles Liles

Associate Director and Head of Corporate Communications & Investor Relations

Mr. Kirk Rosemark RAC

Senior Vice President of Regulatory Affairs & Quality Assurance

Mr. Eric P. Kowack

Senior Vice President of Program Leadership & Alliance Management

Dr. John R. Desjarlais Ph.D.

Executive VP of Research & Chief Scientific Officer

Ms. Celia E. Eckert J.D.

Senior VP, General Counsel & Corporate Secretary

Ms. Jennifer Sandoz

Senior VIce President of Human Resources

Mr. Dane Vincent Leone C.F.A.

Executive VP & Chief Strategy Officer

Dr. Mark Osterman M.D.

Senior Vice President of Clinical Development (Autoimmune)

Dr. Bassil I. Dahiyat Ph.D.

Co-Founder, CEO, President & Director

Mr. Bart Jan Cornelissen

Senior VP & CFO

FAQs

What is Xencor Common Stock share price today?

Xencor Common Stock share price today is $14.08 as on at the close of the market. Xencor Common Stock share today touched a day high of $14.49 and a low of $13.9.

What is the 52 week high and 52 week low for Xencor Common Stock share?

Xencor Common Stock share touched a 52 week high of $18.69 on and a 52 week low of $6.92 on . Xencor Common Stock stock price today i.e. is closed at $14.08,which is 24.67% down from its 52 week high and 103.47% up from its 52 week low.

What is Xencor Common Stock's market capitalisation today?

Xencor Common Stock market capitalisation is $0.00T as on .

How to invest in Xencor Common Stock Stock (XNCR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Xencor Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xencor Common Stock Shares that will get you 0.1065 shares as per Xencor Common Stock share price of $14.08 per share as on June 24, 2026 at 8:46 am IST.

What is the minimum amount required to buy Xencor Common Stock Stock (XNCR) from India?

Indian investors can start investing in Xencor Common Stock (XNCR) shares with as little as ₹94.735 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹947.35 in Xencor Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on Xencor Common Stock share’s latest price of $14.08 as on June 24, 2026 at 8:46 am IST, you will get 0.7102 shares of Xencor Common Stock. Learn more about fractional shares .

What are the returns that Xencor Common Stock has given to Indian investors in the last 5 years?

Xencor Common Stock stock has given -60.9% share price returns and 27.69% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?